Our war against bacteria in peritoneal dialysis, the last 40 years!

International Urology and Nephrology

Volumn 40, Issue 3, 2008, Pages 709-714

  Oreopoulos, Dimitrios G ^a,b   Tzamaloukas, Antonios H ^c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; DIALYSIS FLUID; GENTAMICIN; HYPOCHLORITE SODIUM; IMMUNOGLOBULIN; LACTIC ACID; NYSTATIN; PSEUDOMONIC ACID;

ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BACTERIUM CONTAMINATION; BIOFILM; CATHETER REMOVAL; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS CATHETER; DRUG INTERMITTENT THERAPY; DRUG PACKAGING; EDITORIAL; GRAM NEGATIVE INFECTION; HUMAN; MYCOSIS; PERITONEAL DIALYSIS; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PERITONEAL DIALYSIS; PORTRAITS AS TOPIC;

EID: 48549093433     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9392-1     Document Type: Editorial

References (33)

1. Vas SI (1989) Infections of continuous ambulatory peritoneal dialysis. Infect Dis Clin North Am 3:301-328
2. Christopoulos AI, Diamantopoulos AA, Dimopoulos PA, Gumenos DS, Barbalias GA (2006) Risk of tuberculosis in dialysis patients: association of tuberculin and 2, 4-dinitrochlorobenzene reactivity with risk of tuberculosis. Int Urol Nephrol 38:745-751
3. Lui SL, Yip T, Tse KC, Chan TM, Lai KN, Lo WK (2007) Tuberculous lymphadenitis in patients undergoing continuous ambulatory peritoneal dialysis. Int Urol Nephrol 39:971-974
4. Eslamifar A, Hamkar R, Ramezani A, Ahmadi F, Gachkar L, Jalilvand S, Adibi L, Atabak S, Khameneh A, Ghadimi R, Aghakhani A (2007) Hepatitis G virus exposure in dialysis patients. Int Urol Nephrol 39:1257-1263
5. Vas SI (1983) Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23:83-92
6. Rubin J, Rogers WA, Taylor HM, Everett ED, Prowant BF, Fruto LV, Nolph KD (1980) Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 92:7-13
7. Oreopoulos DG, Robson MD, Izatt S, Clayton S, deVeber GA (1978) A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24:484-489
8. Bazzato G, Landini S, Coli U, Locatello S, Fracasso A, Moracchiello M (1980) A new technique of continuous ambulatory peritoneal dialysis (CAPD): Double-bag system for freedom to the patient and significant reduction of peritonitis. Clin Nephrol 13:251-254
9. Buoncristiani U, Quintaliani G, Cozzari M, Carobi C (1986) Current status of the Y set. Adv Perit Dial 2:165-171
10. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticeli C (1983) Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2(8351):642-644
11. Canadian CAPD Clinical Trials Group, Churchill DN, Taylor DW, Vas SI, Oreopoulos DG, Bettcher KB, Fenton SSA, Fine A, Lavoie S, Page D, Wu G, Beecroft ML, Pemberton R, Wilczynski NL, deVeber GA, Williams W (1989) Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 9:159-163
12. Strippoli GFM, Tong A, Johnson D, Schena FP, Craig JC (2004) Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials. J Am Soc Nephrol 15:2735-2746
13. Lindblad AS, Hamilton RW, Nolph KD, Novak JW (1988) A retrospective analysis of catheter configuration and cuff type: A National CAPD Registry report. Perit Dial Int 8:129-133
14. Lo WK, Lui SL, Li FK, Choy BY, Lam MF, Tse KC, Yip TPS, Ng FSK, Lam SC, Chu WL, Cheng SW (2003) A prospective randomized study of the different peritoneal dialysis catheters. Perit Dial Int 23(Suppl. 2):S127-S131
15. Wikdahl AM, Engman U, Stegmayr B, Sorenson JG (1997) One dose cefuroxime i.v. and i.p. reduces microbial growth in PD peritonitis after catheter insertion. Nephrol Dial Transplant 12:157-160
16. Twardowski ZJ, Prowant BF, Nichols WK, Nolph KD, Khanna R (1998) Six-year experience with Swan neck presternal peritoneal dialysis catheter. Perit Dial Int 18:598-602
17. Dasgupta MK, Bettcher KB, Ulan RA, Burns V, Lam K, Dossetor JB, Costerton JW (1987) Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 7:168-173
18. McCormick BB, Brown PA, Knoll G, Yelle JD, Page D, Biyani M, Lavoie S (2006) Use of embedded peritoneal dialysis catheter: Experience and results from a North American Center. Kidney Int 70:S38-S43
19. Lund L, Jonler M (2007) Peritoneal dialysis catheter placement: Is laparoscopy an option? Int Urol Nephrol 39:625-628
20. Fried L, Bernardini J, Johnston JR, Piraino B (1996) Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7:2176-2182
21. Mupirocin Study Group (1996) Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 7:2403-2408
22. Bernardini J, Piraino B, Holley J, Johnston J, Lutes R (1996) A randomized trial on Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus oral rifampin. Am J Kidney Dis 27:695-700
23. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG (1998) Decrease in Staphylococcus aureus exit-site infection and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 18:261-270
24. Bernardini J, Beneder F, Florio T, Sland J, Palmmontalbano L, Fried L, Piraino B (2005) Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16:539-545
25. Lo WK, Chen CY, Poon JFM, Chan DTM, Cheng IKP (1996) A prospective randomized trial of nystatin prophylaxis for Candida complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 28:549-552
26. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG (1998) Nystatin prophylaxis: Its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 18:583-589
27. Keane WF, Bergeron B, Pence T, Peterson PK, Davison AM (eds) (1987) Challenges for continuous ambulatory peritoneal dialysis. In: Proceedings of the Xth international congress of nephrology. Balliere Tindall, London, pp 1255-1267
28. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PKT, Lye WC, Mujais S, Paterson DL, Perez Fontan M, Ramos A, Schaefer F, Uttley L (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25:107-131
29. Ter Wee PM, Beelen RHJ, Van Den Born J (2003) The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions. Kidney Int 64(Suppl. 88):S75-S83
30. Ahmad S, Sehmi JS, Ahmad-Zakhi KH, Clemenger M, Levy JB, Brown EA (2006) Impact of new dialysis solutions on peritonitis rates. Kidney Int 70:S63-S66
31. Montenegro J, Saracho R, Gallardo I, Martinez I, Munoz R, Quintanilla N (2007) Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 22:1703-1708
32. Fan SL, Pile T, Punzalan S, Raftery MJ, Yacoob MM (2008) Randomized controlled study of biocompatible dialysis solutions: Effect on residual renal function. Kidney Int 73:200-206
33. Fang W, Qian J, Lin A, Ni Z, Bargman JM, Oreopoulos D (in press) Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese center. Nephrol Dial Transplant